MedTrace Logo

French Validation of the Recovery Assessment Scale (RAS-FR)

NCT07667686 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2026-06-25

No results posted yet for this study

Summary

The VAL-RAS-FR study aims to cross-culturally adapt, validate, and develop derived versions of the Recovery Assessment Scale (RAS), an internationally used self-report measure of subjective recovery in mental health. The study will include 260 adult psychiatric patients receiving care at EPSM Metz-Jury in both inpatient and outpatient settings. Participants will complete the French version of the RAS (RAS-FR), the WHOQOL-BREF, and additional self-report questionnaires. A subgroup of participants will complete the RAS-FR again after one month to assess test-retest reliability. The study will also explore existential aspects of recovery through the development of the RAS-FR-EX (Existential Extension) and support the development of a shorter version, the RAS-FR-SF (Short Form), for clinical and research purposes.

Conditions

Interventions

OTHER

Self-report questionnaires

Participants complete self-report questionnaires including the French version of the Recovery Assessment Scale (RAS-FR), the WHOQOL-BREF, and complementary questionnaires related to subjective recovery. The study also includes the exploratory assessment of six additional existential items. A subgroup of 50 participants will complete the RAS-FR again after one month to assess test-retest reliability. No therapeutic intervention, modification of usual care, invasive procedure, or additional medical examination is involved.

Sponsors & Collaborators

  • Centre Hospitalier Régional Metz-Thionville

    collaborator OTHER

  • Groupement Interrégional de Recherche Clinique et d'Innovation

    collaborator OTHER

  • Etablissement Public de Santé Mentale de Metz-Jury

    lead OTHER

Principal Investigators

  • Audrey WILLIG, Psychologist · Clinical Research Unit (URC), EPSM Metz-Jury

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-01-31
Completion
2027-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07667686 on ClinicalTrials.gov